Cholecystokinin and cholecystokinin-A receptor: An attractive treatment strategy for biliary dyskinesia?
Authors:
Open Access
- 21 January 2024
- journal article
- letter
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 30 (3) , 283-285
Abstract
Biliary dyskinesia is a relatively common gastrointestinal disease that is increas ing in incidence as living standards improve. However, its underlying pathogenesis remains unclear, hindering the development of therapeutic drugs. Recently, “Expression and functional study of cholecystokinin-A receptors on the interstitial Cajal-like cells of the guinea pig common bile duct” demonstrated that cholecystokinin (CCK) regulates the contractile function of the common bile duct through interaction with the CCK-A receptor in interstitial Cajal-like cells, contributing to improving the academic understanding of biliary tract dynamics and providing emerging directions for the pathogenesis and clinical management of biliary dyskinesia. This letter provides a brief overview of the role of CCK and CCK-A receptors in biliary dyskinesia from the perspective of animal experiments and clinical studies, and discusses prospects and challenges for the clinical application of CCK and CCK-A receptors as potential therapeutic targets.Keywords
This publication has 8 references indexed in Scilit:
- Expression and functional study of cholecystokinin-A receptors on the interstitial Cajal-like cells of the guinea pig common bile ductWorld Journal of Gastroenterology, 2023
- The critical role of CCK in the regulation of food intake and diet-induced obesityPeptides, 2021
- Cholecystokinin-1 receptor agonist induced pathological findings in the exocrine pancreas of non-human primatesToxicology and Applied Pharmacology, 2020
- Endogenous elevation of plasma cholecystokinin does not prevent gallstonesEuropean Journal of Clinical Investigation, 2015
- Association of caveolin-3 and cholecystokinin A receptor with cholesterol gallstone disease in miceWorld Journal of Gastroenterology, 2014
- Stimulation of Cholecystokinin-A Receptors With GI181771X does not Cause Weight Loss in Overweight or Obese PatientsClinical Pharmacology & Therapeutics, 2007
- Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsiaGut, 2001
- Cholecystokinin-A receptors modulate gastric sensory and motor responses to gastric distension and duodenal lipidGastroenterology, 1996